A dynamic model of colonic concentrations of delayed-release 5-aminosalicylic acid (Asacol)-Reference-Cited by-同舟云学术

A dynamic model of colonic concentrations of delayed-release 5-aminosalicylic acid (Asacol)

Published:2009-06 Issue:11 Volume:29 Page:1193-1201
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

THORPE M. P.,EHRENPREIS E. D.,PUTT K. S.,HANNON B.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2009.03968.x/fullpdf

Reference39 articles.

1. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities;Hanauer;Inflamm Bowel Dis,2006

2. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-durgs used in the management of ulcerative colitis;Sandborn;Aliment Pharmacol Ther,2003

3. Systematic review: adherence issues in the treatment of ulcerative colitis;Kane;Aliment Pharmacol Ther,2006

4. The effect of prescribed daily dose frequency on patient medication compliance;Eisen;Arch Int Med,1990

5. Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care;Kruse;Int J Clin Pharm Ther,1994

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Luminal Fluid Motion Inside an In Vitro Dissolution Model of the Human Ascending Colon Assessed Using Magnetic Resonance Imaging;Pharmaceutics;2021-09-23

2. Modelling and Simulation of the Drug Release from a Solid Dosage Form in the Human Ascending Colon: The Influence of Different Motility Patterns and Fluid Viscosities;Pharmaceutics;2021-06-10

3. Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model;Papillomavirus Research;2018-06

4. Simulated Comparison of Topical and Oral Formulations of 5-Aminosalicylate for the Treatment of Ulcerative Colitis;Inflammatory Bowel Diseases;2013-02

5. A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy;WORLD J GASTROENTERO;2010